Akira Tanimura

Kitamura, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 26 publications

Evaluation of assumed tumour volume in multiple myeloma using dual-energy spectral CT and its correlation between haematological findings.

Evaluation of assumed tumour volume in multiple myeloma using dual-energy spectral CT and its correlation between haematological findings.

Journal: European journal of radiology open

Published: June 03, 2025

Blastic Plasmacytoid Dendritic Cell Neoplasm Developed in Chronic Myeloid Leukemia in Molecular Remission During a Four-Year Treatment-Free Interval After Six Years of Dasatinib Treatment.

Blastic Plasmacytoid Dendritic Cell Neoplasm Developed in Chronic Myeloid Leukemia in Molecular Remission During a Four-Year Treatment-Free Interval After Six Years of Dasatinib Treatment.

Journal: Cureus

Published: June 07, 2024

Posterior reversible encephalopathy syndrome during nilotinib treatment for chronic myeloid leukemia

Posterior reversible encephalopathy syndrome during nilotinib treatment for chronic myeloid leukemia

Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology

Published: January 14, 2024

Bortezomib-thalidomide-dexamethasone-cisplatin-doxorubicin-cyclophosphamide-etoposide as a Salvage and Bridging Regimen before Hematopoietic Stem Cell Transplantation for Relapsed or Refractory Multiple Myeloma.

Bortezomib-thalidomide-dexamethasone-cisplatin-doxorubicin-cyclophosphamide-etoposide as a Salvage and Bridging Regimen before Hematopoietic Stem Cell Transplantation for Relapsed or Refractory Multiple Myeloma.

Journal: Internal medicine (Tokyo, Japan)

Published: April 25, 2022

Impaired B cell terminal differentiation in B cell-specific knockout mice of cell death-defying factor anamorsin.

Impaired B cell terminal differentiation in B cell-specific knockout mice of cell death-defying factor anamorsin.

Journal: Biochemical and biophysical research communications

Published: February 21, 2022

A Case of polychondritis-onset refractory organizing pneumonia with cytopaenia diagnosed as VEXAS syndrome: the disease course of 7 years.

A Case of polychondritis-onset refractory organizing pneumonia with cytopaenia diagnosed as VEXAS syndrome: the disease course of 7 years.

Journal: Rheumatology (Oxford, England)

Published: March 09, 2021

Graft-versus-host disease develops in mice transplanted with lymphocyte-depleted bone marrow cells from signal-transducing adaptor protein-2 transgenic mice.

Graft-versus-host disease develops in mice transplanted with lymphocyte-depleted bone marrow cells from signal-transducing adaptor protein-2 transgenic mice.

Journal: Biochemical and biophysical research communications

Published: November 12, 2020

Autonomous TGFβ signaling induces phenotypic variation in human acute myeloid leukemia.

Autonomous TGFβ signaling induces phenotypic variation in human acute myeloid leukemia.

Journal: Stem cells (Dayton, Ohio)

Published: September 30, 2020

Efficacy of VRD(Bortezomib, Lenalidomide, and Dexamethasone) Consolidation Therapy and Maintenance Therapy with Immunomodulatory Drugs(Thalidomide or Lenalidomide) after Autologous Peripheral Blood Stem Cell Transplantation in the Era of Bortezomib-Containing Induction Therapy-A Single Institution Experience.

Efficacy of VRD(Bortezomib, Lenalidomide, and Dexamethasone) Consolidation Therapy and Maintenance Therapy with Immunomodulatory Drugs(Thalidomide or Lenalidomide) after Autologous Peripheral Blood Stem Cell Transplantation in the Era of Bortezomib-Containing Induction Therapy-A Single Institution Experience.

Journal: Gan to kagaku ryoho. Cancer & chemotherapy

Published: May 15, 2020

Ectonucleotidase CD39 is highly expressed on ATLL cells and is responsible for their immunosuppressive function.

Ectonucleotidase CD39 is highly expressed on ATLL cells and is responsible for their immunosuppressive function.

Journal: Leukemia

Published: December 15, 2019

Signal-transducing adapter protein-1 is required for maintenance of leukemic stem cells in CML.

Signal-transducing adapter protein-1 is required for maintenance of leukemic stem cells in CML.

Journal: Oncogene

Published: August 21, 2019

Endothelial Cell-Selective Adhesion Molecule Contributes to the Development of Definitive Hematopoiesis in the Fetal Liver.

Endothelial Cell-Selective Adhesion Molecule Contributes to the Development of Definitive Hematopoiesis in the Fetal Liver.

Journal: Stem cell reports

Published: February 14, 2019

Showing 1-12 of 26

Last Updated: 09/26/2026